Name | PF-06648671 |
---|
Description | PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease. Alzheimer Disease Phase 1 Discontinued |
---|---|
References | References View Related Products by Target γ-secretase Alzheimer Disease |
Molecular Formula | C25H23ClF4N4O3 |
---|---|
Molecular Weight | 538.928 |